Fixed and embedded 4 mm punch biopsies from Buruli ulcer patients were described previously [6 (link)]. In ulcerated BU lesions (6 patients) punch biopsies were taken 1 cm inside the outer margin of the induration surrounding the ulcer. For BU plaque lesions (2 patients) punch biopsies were collected from the non-ulcerated center of the lesion. Healthy control tissue was obtained at The Whitely Clinic or purchased from AMS Biotechnology (Europe) Ltd (500041028). After removal, all tissues were fixed in neutral formalin, embedded into paraffin (pfm Medical, 9000R2010) and sectioned (5 μm). Sections were deparaffinized, endogenous peroxidase quenched, epitopes unmasked (pH 6 citrate buffer; Sigma, C999) and blocked with horse serum (Vector Laboratories, S-2000-20). The tissue sections were then incubated with either anti-SQSTM1 antibody (Abcam, ab56416) or IgG2a isotype control (Santa Cruz Biotechnology, sc-3878) overnight at 4°C and biotin-conjugated secondary antibody (Vector Laboratories, BA2000). Staining was performed using VECTASTAIN Elite ABC kit (Vector Laboratories, PK-6100) and Vector NovaRED peroxidase substrate (Vector Laboratories, SK-4800). Counterstaining was performed with Shandon Harris Hematoxylin (Thermo Fisher Scientific, 6765001).
Free full text: Click here